The relevance of the immune response in the development of a tumor has been studied by analyzing the leukocyte infiltration within the tumor mass. Human tumors (1) , as well as a number of experimental tumor systems in mice and rats, have been analyzed in this manner (1) (2) (3) (4) (5) (6) (7) (8) . Monocytes and activated macrophages possessing cytotoxic and/or cytostatic activities (1-3, 5, 7) and natural killer (NK) cells (4) have been identified among the infiltrating thymus-independent (i.e., non-T) immunereactive cells which might play a role in tumor rejection.
In addition to non-T immune cells, cytolytic thymus-derived lymphocytes (CTL) have also been identified among the leukocyte infiltrate of solid tumors (3, 4, 8, 9) in mice. The characterization of CTL, extracted by mechanical and enzymatic procedures from murine sarcoma virus (MSV)-induced tumors, indicated that these cytolyric cells consisted mainly of small lymphocytes (3) specific for MSV-associated antigens (3, 4) . Furthermore, intra-tumoral CTL were effective only against tumor target cells of the same H-2 haplotype as the effector cells (4) . In this report we present studies showing that, in addition to active CTL generated in vivo, the T-lymphocyte fraction extracted from MSV-induced tumors in C57BL/6 (B6) mice also contains precursor cells capable of differentiating into active CTL when restimulated in vitro. These CTL showed a high degree of specificity for virus-associated antigens and their cytolytic activity was restricted to tumor target cells of the It-2 n haplotype. The identification of active CTL and of CTL precursor cells within MSV-induced tumors points to the existence of a dynamic state involving T-cell differentiation within the tumor mass before the onset of regression.
Materials and Methods
Tumors. MSV tumors were induced in 4-wk-old inbred C57BL/6 (B6, H-2 b) mice bred in our own animal colony. Each mouse received a 0.2-ml injection, intramuscularly into the thigh, of a cell-free homogenate containing Moloney routine sarcoma and leukemia virus complex (4, 10 (15) . These tumor cell lines were all maintained as stationary suspension cultures.
Lymphoid Cells. The spleen, the inguinal lymph node regional to the MSV-induced tumor (RLN) and the mesenteric lymph node (MLN) were removed and cell suspensions were • prepared as described elsewhere (16) 
Elimination of T Cells. Cell suspensions were depleted of T cells by incubation with an
antiserum prepared by immunizing AKR mice with C3H normal thymus cells (anti-Thy-l.2 serum) and rabbit complement (4).
51Cr-Release Call-Mediated Cytotoxidty Assay.
Cell-mediated anti-tumor cytolytic activity was detected using a modification of the method of Brunner et al. (16) . For primary cytotoxic cells generated in vivo, varied numbers of lymphoid cells were mixed with 3 × 10 a 51Cr-labeled tumor target cells in a final volume 0.4 ml minimal essential medium containing 10% FCS and 10 mM Hepes in 0.5-ml microcentrifuge tubes. After a 19-h incubation at 37°C, the tubes were centrifuged at 11,500 g for 30 s, and 0.2 ml of the supernatant medium was harvested. The radioactivity released from the target cells was measured with a well-type gamma scintillation counter. Lymphocytes harvested from MLTC cultures were assayed for cytolytic activity by incubation with 104 5tCr-labeled target cells at various lymphocyte to target cell ratios in a 0.2-ml total volume in round-bottomed multi-well plates (Linbro Chemical Co., Hamden, Conn.). After a 6-h incubation at 37°C, the supernates were harvested and measured for radioactivity. In all cases, percent specific 51Cr release was calculated by the formula: experimental release --spontaneous release maximum release (in 1 N HCI) -spontaneous release X 100.
Results and Discussion
Adult B6 mice were highly efficient in rejecting tumors induced by MSV. Under our experimental conditions, tumors became apparent 3-4 d after virus injection and reached diameters as large as 2.5 cm on day 9. Tumor rejection occurred rapidly because the tumor mass had completely disappeared by day 15. Previous studies of the CTL response in these mice showed that lymphoid tissues including spleen, peripheral blood, and RLN contained peak CTL numbers on days 8-10, coincidentally with maximum tumor size (4). Studies of the leukocyte fraction extracted by mechanical and enzymatic procedures from the tumors of the same mice revealed the presence of large numbers of active CTL between days 8 and 10; however, maximum CTL numbers were detected on day 12, concurrent with the initiation of tumor regression (4, 9) .
The experiments described in the present communication were designed to detect precursor cells capable of differentiating into MSV tumor-specific CITL. B6 mice were sacrificed on day 8 or 9 after virus inoculation when they bore large tumors, and leukocyte suspensions were prepared from spleen, RLN, MLN, and tumor mass. Each leukocyte suspension was assayed in a 19-h 51Cr-release assay for the presence of primary CTL generated in vivo after tumor induction; other portions of the same leukocyte suspensions were restimulated in culture with syngeneic RBL-5 cells, which share tumor antigens in common with MSV-indueed tumor cells (10, 11, 17) . Fig. 1A shows that, in agreement with previous results (4), leukocytes extracted from the tumor mass contained primary cytolytic cells generated in vivo and capable of destroying syngeneic RBL-5 target cells to a degree comparable to that of leukocytes from the spleen or RLN of the same mice. Under the same experimental conditions, spleen cells from normal B6 mice did not show detectable levels of spontaneous cytotoxicity attributable to NK cells. Previous reports (4, 10) have indicated that the high degree of cytolytic activity of leukocytes from MSV-immune mice on day 9 is mainly a result of thymus-derived effector cells (i.e., CTL).
The same leukocyte suspensions which yielded high numbers of primary CTL also contained precursor cells capable of differentiating into eytolytic effeetor cells in MLTC. The data summarized in Fig. 1 B indicated that the leukocytes, recovered from MLTC after a 6-d cultivation, contained secondary cytolytic effeetor cells detectable in a 6-h 5XCr-release assay. Leukocytes extracted from the tumor mass were capable of generating cytolytic cells comparable in activity to those generated by leukocytes from RLN or MLN and about three times less active than effector cells generated from spleen cell suspensions. This fact pointed to the existence among these leukocyte suspensions of primed MSV-specific CTL precursor cells sensitive to seeondary stimulation by tumor antigen, because parallel incubation of normal B6 spleen cells with RBL-5 stimulator cells for 6 d yielded 7-times less CTL than cultures established with intratumoral leukocytes, and ~16 times less CTL than analogous cultures of MSV-immune spleen cells (Fig. 1 B) . Furthermore, incubation of MSVimmune lymphocytes in the presence of x-irradiated B6 normal spleen cells (instead of RBL-5 cells) revealed a residual cytolytic activity on alCr-labeled RBL-5 target cells (Fig. 1 B) . This residual cytotoxicity was 3-to 10-fold lower than the activity generated in secondary MLTC with the same lymphocyte suspensions incubated with RBL-5-stimulating cells. The latter observations recall data reported by Gillespie et al. (19) in the same tumor system indicating the maturation in vitro of MSV-immune CTL precursor cells in the absence of stimulating tumor antigen.
Cytolytic cells generated in secondary MLTC were specific for antigens induced by Although CTL precursor cells may migrate in mice undergoing tumor rejection, it is not known if this is true in mice bearing progressively growing tumors. Gillespie and collaborators (9) showed that CTL could not be recovered from progressively growing MSV-induced tumors, suggesting perhaps that the CTL precursor traffic had been radically altered. In agreement with this hypothesis, preliminary experiments in our laboratory have indicated that the leukocyte fraction extracted from progressively growing tumors not only was deficient in active CTL generated in vivo, but also appeared to lack CTL precursor cells.
Summary
Leukocyte fractions extracted from the tumor mass and the lymphoid organs of C57BL/6 (B6) mice carrying murine sarcoma virus-induced tumors contained primed cytolytic T-lymphocyte (CTL) precursor cells, in addition to active cytotoxic T cells. These leukocyte fractions gave a secondary response when stimulated in vitro with syngeneic tumor cells, generating large numbers of specific CTL. The activity of these CTL (H-2~ was apparently H-2-restricted, because it was ineffective on tumor targets bearing strongly cross-reacting tumor-specific antigens but with the H-2 d haplotype. were not affected by the same CTL. We propose the existence of a dynamic state involving the migration of primed CTL precursor cells between the lymphoid organs and the tumor mass, as well as the differentiation of these precursor cells within the tumor mass into highly specific CTL.
